IRIS Accounts Production v26.1.10.61 SC834198 Board of Directors 15.1.25 31.3.26 31.3.26 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC8341982025-01-14SC8341982026-03-31SC8341982025-01-152026-03-31SC8341982025-01-14SC834198ns15:Scotland2025-01-152026-03-31SC834198ns14:PoundSterling2025-01-152026-03-31SC834198ns10:Director12025-01-152026-03-31SC834198ns10:PrivateLimitedCompanyLtd2025-01-152026-03-31SC834198ns10:SmallEntities2025-01-152026-03-31SC834198ns10:AuditExempt-NoAccountantsReport2025-01-152026-03-31SC834198ns10:SmallCompaniesRegimeForDirectorsReport2025-01-152026-03-31SC834198ns10:SmallCompaniesRegimeForAccounts2025-01-152026-03-31SC834198ns10:FullAccounts2025-01-152026-03-31SC834198ns10:Director22025-01-152026-03-31SC834198ns10:RegisteredOffice2025-01-152026-03-31SC834198ns5:CurrentFinancialInstruments2026-03-31SC834198ns5:ShareCapital2026-03-31SC834198ns5:RetainedEarningsAccumulatedLosses2026-03-31SC834198ns5:ComputerEquipment2025-01-152026-03-31SC834198ns5:ComputerEquipment2026-03-31SC834198ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-31SC834198ns5:DeferredTaxation2025-01-152026-03-31SC834198ns5:DeferredTaxation2026-03-31SC834198ns5:RetainedEarningsAccumulatedLosses2025-01-152026-03-31
REGISTERED NUMBER: SC834198 (Scotland)













Unaudited Financial Statements

for the Period

15 January 2025 to 31 March 2026

for

Midfield Medical Limited

Midfield Medical Limited (Registered number: SC834198)






Contents of the Financial Statements
for the Period 15 January 2025 to 31 March 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Midfield Medical Limited

Company Information
for the Period 15 January 2025 to 31 March 2026







DIRECTORS: Dr D A J Smith
Dr G B Fleming





REGISTERED OFFICE: 90 Lasswade Road
Edinburgh
EH16 6SU





REGISTERED NUMBER: SC834198 (Scotland)





ACCOUNTANTS: A H & Co Ltd
Chartered Accountants
6 Logie Mill
Edinburgh
Lothian
EH7 4HG

Midfield Medical Limited (Registered number: SC834198)

Balance Sheet
31 March 2026

Notes £    £   
FIXED ASSETS
Tangible assets 4 746

CURRENT ASSETS
Debtors 5 5,210
Cash at bank 24,438
29,648
CREDITORS
Amounts falling due within one year 6 7,757
NET CURRENT ASSETS 21,891
TOTAL ASSETS LESS CURRENT
LIABILITIES

22,637

PROVISIONS FOR LIABILITIES 7 142
NET ASSETS 22,495

CAPITAL AND RESERVES
Called up share capital 8 100
Retained earnings 9 22,395
22,495

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 June 2026 and were signed on its behalf by:





Dr D A J Smith - Director


Midfield Medical Limited (Registered number: SC834198)

Notes to the Financial Statements
for the Period 15 January 2025 to 31 March 2026

1. STATUTORY INFORMATION

Midfield Medical Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is stated net of trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the balance sheet date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the balance sheet date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Tangible fixed assets
Tangible fixed assets are stated at cost, net of depreciation and any provision for impairment. Depreciation is
provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less
residual value, of each asset on a straight line basis over it's expected useful life, as follows:

Computer Equipment - 20% on cost

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Midfield Medical Limited (Registered number: SC834198)

Notes to the Financial Statements - continued
for the Period 15 January 2025 to 31 March 2026

2. ACCOUNTING POLICIES - continued

Provisions
Provisions are recognised when the company has a present obligation (legal or constructive) as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation.

Exemption from preparing a cash flow statement
Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as a small company.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
Additions 984
At 31 March 2026 984
DEPRECIATION
Charge for period 238
At 31 March 2026 238
NET BOOK VALUE
At 31 March 2026 746

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 5,210

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 5,111
Other creditors 2,646
7,757

7. PROVISIONS FOR LIABILITIES
£   
Deferred tax 142

Deferred
tax
£   
Provided during period 142
Balance at 31 March 2026 142

Midfield Medical Limited (Registered number: SC834198)

Notes to the Financial Statements - continued
for the Period 15 January 2025 to 31 March 2026

8. CALLED UP SHARE CAPITAL

Alloted, issued and fully paid

Number:

Class:
Nominal
Value:


£

850 Ordinary A Shares 0.1 85
50 Ordinary B Shares 0.1 5
50 Ordinary C Shares 0.1 5
50 Ordinary D Shares 0.1 5
100

9. RESERVES
Retained
earnings
£   

Profit for the period 22,395
At 31 March 2026 22,395

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

As at 31 March 2026, the company owed the directors £666.

11. RELATED PARTY DISCLOSURES

There were no related party transactions in the year.

12. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.